Home
Tonix Pharmaceuticals Holding TNXP paid Strategic Marketing Innovations $40K for lobbying in Q2 2026 · Health Issues, Defense
Trade details
- Type
- Lobbying report
- Amount
- $40,000
- Quarter
- Q2 2026
- Client
- Tonix Pharmaceuticals
- Reported
- 26/07/17
Up 0.0% from last quarter
What else happened in Tonix Pharmaceuticals Holding around then
Filed or reported within 30 days of the trade day · 05/31~07/30Tonix Pharmaceuticals's other lobbying reports
- Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
LobbyingTonix Pharmaceuticals Holding
TNXP
$20K
$20K
Reported 08/07
for Q3
- Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
LobbyingTonix Pharmaceuticals Holding
TNXP
$30K
$30K
Reported 07/20
for Q2
- Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
LobbyingTonix Pharmaceuticals Holding
TNXP
$40K
$40K
Reported 07/19
for Q2
- Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
LobbyingTonix Pharmaceuticals Holding
TNXP
$20K
$20K
Reported 07/18
for Q2
- Tonix Pharmaceuticals
LobbyingTonix Pharmaceuticals Holding
LobbyingTonix Pharmaceuticals Holding
TNXP
$50K
$50K
Reported 07/17
for Q2